A regimen consisting of docetaxel, cisplatin and fluorouracil used for the treatment of squamous cell head and neck cancer and gastric cancer. OR An abbreviation for a chemotherapy combination used to treat certain types of head and neck cancer and stomach cancer. It includes the drugs docetaxel (Taxotere), cisplatin (Platinol), and fluorouracil. Also called DCF, docetaxel-cisplatin-fluorouracil, Taxotere-Platinol-fluorouracil, and TPF.